Circumventing anti-androgen resistance by molecular design.
McGinley
Paula L
PL
Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, USA.
Koh
John T
JT
D000726:Androgen Antagonists / Q000737:chemistry* / Q000494:pharmacology*; D059002:Androgen Receptor Antagonists; D000728:Androgens / Q000378:metabolism; D000813:Anilides / Q000737:chemistry / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D015195:Drug Design; D019008:Drug Resistance, Neoplasm; D017930:Genes, Reporter / Q000235:genetics; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D009570:Nitriles / Q000737:chemistry / Q000494:pharmacology; D011944:Receptors, Androgen / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D014105:Tosyl Compounds / Q000737:chemistry / Q000494:pharmacology
D000726:Androgen Antagonists; D059002:Androgen Receptor Antagonists; D000728:Androgens; D000813:Anilides; D000970:Antineoplastic Agents; D009570:Nitriles; D011944:Receptors, Androgen; D014105:Tosyl Compounds; C053541:bicalutamide